Want to see AU:MSX full AI Analyst Report?
Neuroscientific Biopharmaceuticals Ltd. (MSX) Financial Statements
Neuroscientific Biopharmaceuticals Ltd. Financial Overview
Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently $19.49M. The company's EPS TTM is $-0.01; its P/E ratio is -3.88; Neuroscientific Biopharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 2.21M | $ 4.95M | $ 0.00 |
| Gross Profit | $ -1.38M | $ -92.78K | $ -91.34K | $ -57.85K | $ -64.92K |
| Operating Income | $ -5.11M | $ -1.92M | $ -2.06M | $ -6.12M | $ -10.50M |
| EBITDA | $ -3.72M | $ -1.92M | $ -1.80M | $ -5.96M | $ -10.37M |
| Net Income | $ -4.69M | $ -1.85M | $ 324.21K | $ -1.07M | $ -10.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.63M | $ 7.27M | $ 4.95M | $ 4.91M | $ 7.22M |
| Total Assets | $ 15.18M | $ 16.96M | $ 5.44M | $ 5.29M | $ 7.74M |
| Total Debt | $ 87.04K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -2.54M | $ -7.27M | $ -4.95M | $ -4.91M | $ -7.22M |
| Total Liabilities | $ 374.89K | $ 149.22K | $ 85.68K | $ 597.36K | $ 2.22M |
| Stockholders' Equity | $ 14.81M | $ 16.81M | $ 5.35M | $ 4.69M | $ 5.52M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ -941.33K | $ 42.43K | $ -2.30M | $ -6.95M |
| Operating Cash Flow | $ -2.61M | $ -941.33K | $ 44.25K | $ -2.30M | $ -6.94M |
| Investing Cash Flow | $ -2.00M | $ -36.04K | $ -1.81K | $ 0.00 | $ -3.87K |
| Financing Cash Flow | $ -30.26K | $ 3.29M | $ 0.00 | $ 0.00 | $ 0.00 |
Currency in AUD